Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (576) 576
Newspaper Article (39) 39
Patent (14) 14
Book Chapter (7) 7
Magazine Article (4) 4
Book / eBook (3) 3
Book Review (2) 2
Conference Proceeding (2) 2
Reference (2) 2
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (349) 349
life sciences & biomedicine (326) 326
humans (298) 298
male (190) 190
biological and medical sciences (189) 189
female (181) 181
infectious diseases (177) 177
medical sciences (176) 176
middle aged (144) 144
microbiology (128) 128
adult (123) 123
aged (109) 109
abridged index medicus (107) 107
staphylococcus aureus (77) 77
immunology (72) 72
infections (72) 72
endocarditis (62) 62
treatment outcome (60) 60
research (59) 59
bacterial diseases (57) 57
risk factors (57) 57
human bacterial diseases (55) 55
anti-bacterial agents - therapeutic use (53) 53
prospective studies (52) 52
animals (51) 51
mortality (49) 49
heart (47) 47
cardiology. vascular system (46) 46
general & internal medicine (46) 46
antibiotics (43) 43
health aspects (42) 42
bacteremia (41) 41
medicine, general & internal (41) 41
care and treatment (40) 40
pharmacology & pharmacy (40) 40
staphylococcal infections - microbiology (39) 39
aged, 80 and over (36) 36
drug therapy (36) 36
cardiovascular system & cardiology (35) 35
staphylococcal infections - drug therapy (35) 35
adolescent (34) 34
cardiac & cardiovascular systems (33) 33
clinical trials (33) 33
staphylococcus infections (33) 33
analysis (32) 32
endocarditis, bacterial - microbiology (31) 31
vancomycin - therapeutic use (31) 31
diagnosis (30) 30
endocardial and cardiac valvular diseases (30) 30
cohort studies (29) 29
pharmacology. drug treatments (29) 29
anti-bacterial agents - pharmacology (28) 28
bacteremia - microbiology (28) 28
double-blind method (28) 28
epidemiology (28) 28
skin diseases, bacterial - drug therapy (27) 27
fundamental and applied biological sciences. psychology (26) 26
pathogens (26) 26
echocardiography (25) 25
general aspects (25) 25
retrospective studies (25) 25
staphylococcal infections (25) 25
staphylococcus aureus - isolation & purification (25) 25
united states (25) 25
staphylococcal infections, streptococcal infections, pneumococcal infections (24) 24
anti-bacterial agents - administration & dosage (23) 23
antibiotics. antiinfectious agents. antiparasitic agents (23) 23
blood (23) 23
life sciences (23) 23
staphylococcus aureus - drug effects (23) 23
vancomycin (23) 23
infective endocarditis (22) 22
bacteremia - drug therapy (21) 21
bacteria (21) 21
miscellaneous (21) 21
patients (21) 21
skin (21) 21
surgery (21) 21
usage (21) 21
young adult (20) 20
anti-bacterial agents - adverse effects (19) 19
antibacterial agents (19) 19
drug resistance (19) 19
incidence (19) 19
medical research (19) 19
patient outcomes (19) 19
physical sciences (19) 19
staphylococcal infections - mortality (19) 19
bacterial sepsis (18) 18
cardiovascular disease (18) 18
child (18) 18
infection (18) 18
public, environmental & occupational health (18) 18
studies (18) 18
aminoglycosides - therapeutic use (17) 17
bacteriology (17) 17
biochemistry & molecular biology (17) 17
follow-up studies (17) 17
internal medicine (17) 17
prognosis (17) 17
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Dr. Corey and colleagues reply
by Corey, G Ralph and Corey, G. Ralph and Jiang, Hai and Jiang, Hai and Moeck, Greg and Moeck, Greg
The New England journal of medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 12, pp. 1162 - 1163
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen
by Martin E. Stryjewski and G. Ralph Corey
Clinical infectious diseases, ISSN 1058-4838, 1/2014, Volume 58, Issue 1, pp. S10 - S19
Pathogens | Transposons | Antibiotics | Plasmids | Methicillin resistant staphylococcus aureus | Infections | Genetic mutation | Staphylococcus aureus | Staphylococcus | Bacteremia | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological Evolution | Methicillin-Resistant Staphylococcus aureus - physiology | Point Mutation | Staphylococcal Infections - epidemiology | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Drug Resistance, Bacterial | Anti-Bacterial Agents - pharmacology | Gene Transfer, Horizontal | Staphylococcal Infections - microbiology | Glycopeptides - pharmacology | Methicillin-Resistant Staphylococcus aureus - genetics | Physiological aspects | Anti-infective agents | Research | Drug resistance | Bacteria | Penicillin | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study
by G. Ralph Corey and Samantha Good and Hai Jiang and Greg Moeck and Matthew Wikler and Sinikka Green and Paul Manos and Richard Keech and Rajesh Singh and Barry Heller and Natalia Bubnova and William O'Riordan and SOLO II Investigators
Clinical infectious diseases, ISSN 1058-4838, 1/2015, Volume 60, Issue 2, pp. 254 - 262
ARTICLES AND COMMENTARIES | acute bacterial skin and skin structure infection (ABSSSI) | vancomycin | oritavancin | lipoglycopeptide | methicillin-resistant Staphylococcus aureus (MRSA) | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Skin Diseases, Bacterial - drug therapy | Glycopeptides - therapeutic use | Gram-Positive Bacterial Infections - pathology | Young Adult | Anti-Bacterial Agents - therapeutic use | Administration, Intravenous | Vancomycin - therapeutic use | Adolescent | Aged, 80 and over | Adult | Female | Aged | Soft Tissue Infections - drug therapy | Gram-Positive Bacterial Infections - drug therapy | Confidence intervals | Gram-positive bacteria | Skin diseases | Bacterial infections | Antibiotics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double-Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin-Structure Infection
by G. Ralph Corey and Mark Wilcox and George H. Talbot and H. David Friedland and Tanya Baculik and Gary W. Witherell and Ian Critchley and Anita F. Das and Dirk Thye
Clinical infectious diseases, ISSN 1058-4838, 9/2010, Volume 51, Issue 6, pp. 641 - 650
Pathogens | Antimicrobials | Abscesses | Streptococcus pyogenes | Infections | Skin | ARTICLES AND COMMENTARIES | Medical cures | Dosage | Staphylococcus aureus | Bacteremia | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Middle Aged | Male | Skin Diseases, Bacterial - drug therapy | Aztreonam - pharmacology | Young Adult | Vancomycin - pharmacology | Aged, 80 and over | Adult | Female | Anti-Bacterial Agents - adverse effects | Aztreonam - adverse effects | Cephalosporins - pharmacology | Cephalosporins - adverse effects | Vancomycin - administration & dosage | Double-Blind Method | Treatment Outcome | Cephalosporins - administration & dosage | Vancomycin - adverse effects | Drug Therapy, Combination - methods | Aztreonam - administration & dosage | Adolescent | Aged | Anti-Bacterial Agents - pharmacology | Anti-Bacterial Agents - administration & dosage | Infectious skin diseases | Usage | Patient outcomes | Aztreonam | Vancomycin | Drug therapy | Health aspects | Clinical trials | Staphylococcus infections | Antibiotics | Drug resistance | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Epidemiology of Methicillin-Resistant Staphylococcus aureus
by Helen W. Boucher and G. Ralph Corey
Clinical infectious diseases, ISSN 1058-4838, 6/2008, Volume 46, Issue 5, pp. S344 - S349
Infectious diseases | Antibiotics | Mortality | Virulence | Predisposing factors | Endocarditis | Methicillin resistant staphylococcus aureus | Infections | Epidemiology | Staphylococcus aureus | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Community-Acquired Infections - transmission | Geography | Community-Acquired Infections - mortality | United States - epidemiology | Community-Acquired Infections - epidemiology | Staphylococcus aureus - isolation & purification | Humans | Cross Infection - mortality | Incidence | Cross Infection - transmission | Staphylococcal Infections - transmission | Staphylococcal Infections - mortality | Staphylococcal Infections - epidemiology | Cross Infection - microbiology | Staphylococcal Infections - microbiology | Methicillin Resistance | Staphylococcus aureus - drug effects | Community-Acquired Infections - microbiology | Cross Infection - epidemiology | Forecasts and trends | Cross infection | Nosocomial infections | Staphylococcus aureus infections | Distribution | Health care | Staphylococcus infections | Risk factors | Morbidity | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Telavancin versus Vancomycin for the Treatment of Complicated Skin and Skin-Structure Infections Caused by Gram-Positive Organisms
by Martin E. Stryjewski and Donald R. Graham and Samuel E. Wilson and William O'Riordan and David Young and Arnold Lentnek and Douglas P. Ross and Vance G. Fowler and Alan Hopkins and H. David Friedland and Steven L. Barriere and Michael M. Kitt and G. Ralph Corey and Assessment of Telavancin in Complicated Skin and Skin-Structure Infections Study and on behalf of the Assessment of Telavancin in Complicated Skin and Skin‐Structure Infections Study
Clinical infectious diseases, ISSN 1058-4838, 6/2008, Volume 46, Issue 11, pp. 1683 - 1693
Pathogens | Medical treatment | Articles and Commentaries | Methicillin resistant staphylococcus aureus | Medications | Infections | Skin | Medical cures | Dosage | Epidemiology | Staphylococcus aureus | Biological and medical sciences | Infectious diseases | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Double-Blind Method | Gram-Positive Bacteria - drug effects | Humans | Middle Aged | Male | Treatment Outcome | Skin Diseases, Infectious - microbiology | Vancomycin - therapeutic use | Skin Diseases, Infectious - drug therapy | Adult | Female | Gram-Positive Bacteria - growth & development | Gram-Positive Bacterial Infections - drug therapy | Aminoglycosides - therapeutic use | Infectious skin diseases | Care and treatment | Antibiotics | Gram-positive bacterial infections | Dosage and administration | Research | Comparative analysis | Peptides | Gram-positive bacteria | Clinical trials | Skin diseases | Staphylococcus infections | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial
by Moran, Gregory J, Prof and Fang, Edward, MD and Corey, G Ralph, Prof and Das, Anita F, PhD and De Anda, Carisa, PharmD and Prokocimer, Philippe, Dr
The Lancet infectious diseases, ISSN 1473-3099, 2014, Volume 14, Issue 8, pp. 696 - 705
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Biological and medical sciences | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Linezolid | Organophosphates - administration & dosage | Double-Blind Method | Administration, Oral | Humans | Middle Aged | Male | Treatment Outcome | Skin Diseases, Bacterial - drug therapy | Oxazolidinones - administration & dosage | Young Adult | Administration, Intravenous | Oxazoles - administration & dosage | Adolescent | Aged, 80 and over | Adult | Female | Aged | Anti-Bacterial Agents - administration & dosage | Acetamides - administration & dosage | Clinical trials | Skin | Drug resistance | Health aspects | Emergency medicine | Dermatology | Analysis | Formulae, receipts, prescriptions | Dermatologic agents | Gram-positive bacteria | Staphylococcus infections | Antibiotics | Patients | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
by Ethan Rubinstein and Tahaniyat Lalani and G. Ralph Corey and Zeina A. Kanafani and Esteban C. Nannini and Marcelo G. Rocha and Galia Rahav and Michael S. Niederman and Marin H. Kollef and Andrew F. Shorr and Patrick C. Lee and Arnold L. Lentnek and Carlos M. Luna and Jean-Yves Fagon and Antoni Torres and Michael M. Kitt and Fredric C. Genter and Steven L. Barriere and H. David Friedland and Martin E. Stryjewski and ATTAIN Study Group and for the ATTAIN Study Group
Clinical infectious diseases, ISSN 1058-4838, 1/2011, Volume 52, Issue 1, pp. 31 - 40
Pathogens | Pneumonia | Infectious diseases | Antibiotics | Medications | Cultural groups | Infections | Ventilator associated pneumonia | ARTICLES AND COMMENTARIES | Medical cures | Staphylococcus aureus | Human infectious diseases. Experimental studies and models | General aspects | Respiratory system : syndromes and miscellaneous diseases | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Pneumology | Double-Blind Method | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Middle Aged | Male | Treatment Outcome | Pneumonia, Staphylococcal - microbiology | Lipoglycopeptides | Cross Infection - drug therapy | Anti-Bacterial Agents - therapeutic use | Pneumonia, Staphylococcal - drug therapy | Vancomycin - therapeutic use | Cross Infection - microbiology | Aged, 80 and over | Adult | Female | Aged | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Aminoglycosides - therapeutic use | Usage | Bacterial pneumonia | Gram-positive bacteria | Cross infection | Nosocomial infections | Vancomycin | Drug therapy | Health aspects | Risk factors | Hospitals | Mortality | Staphylococcus infections | Index Medicus | and Commentaries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
by Fowler, Vance G and Boucher, Helen W and Corey, G. Ralph and Abrutyn, Elias and Karchmer, Adolf W and Rupp, Mark E and Levine, Donald P and Chambers, Henry F and Tally, Francis P and Vigliani, Gloria A and Cabell, Christopher H and Link, Arthur Stanley and DeMeyer, Ignace and Filler, Scott G and Zervos, Marcus and Cook, Paul and Parsonnet, Jeffrey and Bernstein, Jack M and Price, Connie Savor and Forrest, Graeme N and Fätkenheuer, Gerd and Gareca, Marcelo and Rehm, Susan J and Brodt, Hans Reinhardt and Tice, Alan and Cosgrove, Sara E and S aureus Endocarditis Bacteremia and S. aureus Endocarditis and Bacteremia Study Group
The New England journal of medicine, ISSN 0028-4793, 08/2006, Volume 355, Issue 7, pp. 653 - 665
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Infectious diseases | Bacterial diseases | Human bacterial diseases | Biological and medical sciences | Medical sciences | Bacterial sepsis | Endocarditis, Bacterial - drug therapy | Staphylococcal Infections - drug therapy | Gentamicins - therapeutic use | Penicillins - therapeutic use | Humans | Middle Aged | Bacteremia - drug therapy | Male | Treatment Outcome | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Vancomycin - therapeutic use | Aged, 80 and over | Endocarditis, Bacterial - microbiology | Adult | Female | Aged | Staphylococcal Infections - microbiology | Methicillin Resistance | Staphylococcus aureus - drug effects | Daptomycin - therapeutic use | Drug therapy | Bacteremia | Endocarditis | Substance abuse treatment | Committees | Gram-positive bacteria | Staphylococcus infections | Drug dosages | Patients | Bacteriology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: A randomized trial
by Fowler Jr, Vance G and Allen, Keith B and Moreira Jr, Edson D and Moustafa, Moustafa and Isgro, Frank and Boucher, Helen W and Corey, G. Ralph and Carmeli, Yehuda and Betts, Robert and Hartzel, Jonathan S and Chan, Ivan S. F and McNeely, Tessie B and Kartsonis, Nicholas A and Guris, Dalya and Onorato, Matthew T and Smugar, Steven S and DiNubile, Mark J and Meulen, Ajoke Sobanjo-Ter
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 04/2013, Volume 309, Issue 13, pp. 1368 - 1378
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Humans | Middle Aged | Vaccination | Bacteremia - mortality | Male | Staphylococcal Vaccines - administration & dosage | Preoperative Care | Surgical Wound Infection - prevention & control | Young Adult | Staphylococcal Infections - mortality | Cardiovascular Surgical Procedures | Bacteremia - prevention & control | Staphylococcal Vaccines - adverse effects | Thoracic Surgical Procedures - adverse effects | Adolescent | Aged, 80 and over | Adult | Female | Staphylococcal Infections - prevention & control | Aged | Staphylococcus aureus | Sternotomy - adverse effects | Immunization | Heart surgery | Mortality | Clinical trials | Staphylococcus infections | Vaccines | Patients
Journal Article
Details down arrow
11. Full Text Staphylococcus aureus Bboodstream infections: Definitions and treatment
by Corey, G. Ralph
Clinical infectious diseases, ISSN 1058-4838, 05/2009, Volume 48, Issue 4, pp. S254 - S259
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights